Nath Bio-Genes (NATHBIOGEN) | Stock Overview & Key Data
Nath Bio-Genes Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹585.00 on May 7, 2018
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nath Bio-Genes
NATHBIOGEN
|
3.27B Small-cap | 1.72% | 5.03% | 19.82% | 10.69% | 8.15% | -16.73% | -13.64% | -59.77% | 82.68% | 584.86% | 584.86% |
|
UPL
UPLPP
|
620.31B Large-cap | 0.00% | 0.00% | 16.46% | 24.26% | 24.26% | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% |
|
Coromandel
COROMANDEL
|
588.05B Large-cap | 13.43% | 6.46% | 1.40% | -14.48% | -12.23% | -16.35% | 104.66% | 118.48% | 711.13% | 471.21% | 7,138.29% |
|
Kaveri Seed Company
KSCL
|
48.33B Small-cap | 4.12% | -4.14% | 8.67% | -9.80% | -9.67% | -33.23% | 72.04% | 20.43% | 96.24% | 1,042.55% | 2,016.69% |
|
Dhanuka Agritech
DHANUKA
|
45.54B Small-cap | -0.19% | -0.78% | 9.99% | -10.12% | -8.70% | -35.13% | 36.26% | 11.62% | 68.20% | 1,114.83% | 1,114.83% |
|
Madhya Bharat Agro
MBAPL
|
44.41B Small-cap | 3.75% | 5.86% | 26.12% | 39.98% | 32.38% | 61.61% | 74.48% | 1,952.84% | 7,351.06% | 7,351.06% | 7,351.06% |
Ownership & Short Interest
Calculate Your Nath Bio-Genes Investment Returns
Long-Term Investment Performance Analysis
Nath Bio-Genes stock price in Aug 2016 was ₹103.70, A ₹1,000.00 lump sum investment in Nath Bio-Genes made 9 years ago would be worth approximately ₹1,629.89 today, representing a solid return of 62.99%. This translates to an annualized return (CAGR) of 5.07%.
9 Years 10 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NATHBIOGEN's 52-week high and low?
- In the last 52 weeks, Nath Bio-Genes reached a high of ₹238.69 (on July 10, 2025) and a low of ₹126.15 (on March 30, 2026).
- What is the market cap and P/E ratio for NATHBIOGEN?
- Curious about Nath Bio-Genes's size and valuation? Its market capitalization stands at 3.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.55, and the forward P/E (looking ahead) is N/A.
- Does NATHBIOGEN pay dividends? If so, what's the yield?
- Yes, Nath Bio-Genes is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.17%, and the company has paid an average of ₹2.00 per share annually over the past 3 years.
- Who are Nath Bio-Genes's main competitors or similar companies to consider before investing?
When looking at Nath Bio-Genes, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UPL
UPLPP620.31B Basic Materials Agricultural Inputs 104.96% 104.96% Coromandel
COROMANDEL588.05B Basic Materials Agricultural Inputs -16.35% 104.66% Kaveri Seed Company
KSCL48.33B Basic Materials Agricultural Inputs -33.23% 72.04% Dhanuka Agritech
DHANUKA45.54B Basic Materials Agricultural Inputs -35.13% 36.26% Madhya Bharat Agro
MBAPL44.41B Basic Materials Agricultural Inputs 61.61% 74.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nath Bio-Genes (India) Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Nath Bio-Genes's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.99%, the Debt to Equity ratio from the most recent quarter is 22.77, and its Gross Profit Margin stands at 56.37%.
- What is the recent revenue and earnings growth for NATHBIOGEN?
- Looking at Nath Bio-Genes's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 78.90%, and quarterly earnings saw a YoY growth of -39.40%.
- How much of NATHBIOGEN stock is held by insiders and institutions?
- Wondering who owns Nath Bio-Genes stock? Company insiders (like executives and directors) hold about 61.39% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.